Generation Bio Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Generation Bio Stock Summary

Generation Bio competes with Monte Rosa, Nkarta, Lyell Immunopharma, Sana Biotechnology, and Kronos Bio. Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts. Generation Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 150 people.

Generation Bio Key Financial Ratios

Generation Bio Key Balance Sheet Accounts

Generation Bio Key Income Statement Accounts

Generation Bio Key Cash Accounts

Generation Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Generation Bio's current stock value. Our valuation model uses many indicators to compare Generation Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Generation Bio competition to find correlations between indicators driving Generation Bio's intrinsic value. More Info.Generation Bio Co is rated below average in return on equity category among its peers. It is rated # 5 in return on asset category among its peers . At this time, Generation Bio's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Generation Bio's earnings, one of the primary drivers of an investment's value.

Generation Bio Systematic Risk

Today, most investors in Generation Bio Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Generation Bio's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Generation Bio growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Generation Bio help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Generation Bio Co. We use our internally-developed statistical techniques to arrive at the intrinsic value of Generation Bio Co based on widely used predictive technical indicators. In general, we focus on analyzing Generation Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Generation Bio's daily price indicators and compare them against related drivers.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Generation Bio Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Generation Bio. If investors know Generation will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Generation Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Generation Bio is measured differently than its book value, which is the value of Generation that is recorded on the company's balance sheet. Investors also form their own opinion of Generation Bio's value that differs from its market value or its book value, called intrinsic value, which is Generation Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Generation Bio's market value can be influenced by many factors that don't directly affect Generation Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Generation Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Generation Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Generation Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.